Insiders Updates
A Guide To The Risks Of Investing In Zentalis Pharmaceuticals Inc (ZNTL)
In a filing, Zentalis Pharmaceuticals Inc revealed its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
Menu
In a filing, Zentalis Pharmaceuticals Inc revealed its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Zentalis Pharmaceuticals Inc’s filing revealed that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr 30
Zentalis Pharmaceuticals Inc’s recent filing unveils that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Zentalis Pharmaceuticals Inc revealed its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Zentalis Pharmaceuticals Inc’s recently made public that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals